Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting.

    Gilbert J, Raboud J, Zinman B.

    Diabetes Care. 2004 Apr;27(4):990-4.PMID: 15047662 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin resistance as a predictor for restenosis after coronary stenting.

    Nishio K, Fukui T, Tsunoda F, Kawamura K, Itoh S, Konno N, Ozawa K, Katagiri T.

    Int J Cardiol. 2005 Aug 18;103(2):128-34. Epub 2004 Dec 19.PMID: 16080969 [PubMed - indexed for MEDLINE]Related articles

    3.

    Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.

    Rodriguez AE, Rodriguez Alemparte M, Fernandez Pereira C, Vigo CF, Sampaolesi A, Bernardi V, Marchand E, Tronge J, Palacios IF; LASMAL II Investigators.

    Am Heart J. 2005 Jul;150(1):188.PMID: 16086559 [PubMed - indexed for MEDLINE]Related articles

    4.

    Provisional stenting for multivessel PCI.

    Han B, Liu L, Aboud M, Nahir M, Hasin Y.

    Int J Cardiovasc Intervent. 2005;7(1):46-51.PMID: 16019615 [PubMed - indexed for MEDLINE]Related articles

    5.

    Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation.

    Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'Ambrosio A, Montesanti R, Di Sciascio G.

    Circulation. 2005 Jan 4;111(1):70-5.PMID: 15630038 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.

    Wong CK, Hammett CJ, The R, French JK, Gao W, Webber BJ, Elliott JM, Hamer AW, Ormiston JA, Webster MW, Stewart RA, Ameratunga RV, White HD.

    Heart. 2004 Nov;90(11):1299-302.PMID: 15486126 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Angiographic and clinical outcomes of rosiglitazone in patients with type 2 diabetes mellitus after percutaneous coronary interventions: a single center experience.

    Fang CC, Ng Jao YT, Yi-Chen, Yu CL, Chen CL, Wang SP.

    Angiology. 2007 Oct-Nov;58(5):523-34.PMID: 18024934 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).

    Yee KM, Buller CE, Catellier D, Cohen EA, Carere RC, Anderson T, Berger P, Burton JR, Barbeau G, Teo KK, Dzavik V; Total Occlusion Study of Canada (TOSCA) Investigators.

    Catheter Cardiovasc Interv. 2005 Oct;66(2):178-84.PMID: 15977265 [PubMed - indexed for MEDLINE]Related articles

    9.

    Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.

    Tan HC, Lim YT, Rosli TL, Sim KH, Tan KH, Lee CH, Ismail O, Azman W.

    Am Heart J. 2004 Dec;148(6):1007-11.PMID: 15632886 [PubMed - indexed for MEDLINE]Related articles

    10.

    A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.

    Xu B, Li JJ, Yang YJ, Ma WH, Chen JL, Qiao SB, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL.

    Chin Med J (Engl). 2006 Apr 5;119(7):533-8.PMID: 16620692 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries.

    Scheen AJ, Warzée F.

    Diabetes Care. 2004 Jul;27(7):1840-1. No abstract available. PMID: 15220280 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.

    Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, Gómez-Hospital JA, Alfonso F, Hernández-Antolín R, Goicolea J, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C; DIABETES Investigators.

    Circulation. 2005 Oct 4;112(14):2175-83.PMID: 16203930 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.

    Kitoga M, Pasquet A, Preumont V, Kefer J, Hermans MP, Vanoverschelde JL, Buysschaert M.

    Diabetes Metab. 2008 Feb;34(1):62-7.PMID: 18069029 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Gender and restenosis after coronary artery stenting.

    Mehilli J, Kastrati A, Bollwein H, Dibra A, Schühlen H, Dirschinger J, Schömig A.

    Eur Heart J. 2003 Aug;24(16):1523-30.PMID: 12919777 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Coronary stenting or balloon angioplasty for chronic total coronary occlusions: the Taiwan experience (a single-center report).

    Fang CC, Jao YT, Chen Y, Wang SP.

    Angiology. 2005 Sep-Oct;56(5):525-37.PMID: 16193191 [PubMed - indexed for MEDLINE]Related articles

    16.

    Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes.

    Bakhai A, Hill RA, Dundar Y, Dickson R, Walley T.

    Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004588. Review.PMID: 15674954 [PubMed - indexed for MEDLINE]Related articles

    17.

    Influence of alcohol consumption on restenosis rate after percutaneous transluminal coronary angioplasty and stent implantation.

    Niroomand F, Hauer O, Tiefenbacher CP, Katus HA, Kuebler W.

    Heart. 2004 Oct;90(10):1189-93.PMID: 15367521 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Previous cytomegalovirus infection and restenosis after aggressive angioplasty with provisional stenting.

    Mueller C, Hodgson JM, Bestehorn HP, Brutsche M, Perruchoud AP, Marsch S, Roskamm H, Buettner HJ.

    J Interv Cardiol. 2003 Aug;16(4):307-13.PMID: 14562670 [PubMed - indexed for MEDLINE]Related articles

    19.

    Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.

    Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, Tondi S, Saia F, Cooke RM, Guastaroba P, Grilli R, Marzocchi A, Maresta A.

    Circulation. 2008 Feb 19;117(7):923-30. Epub 2008 Feb 4.PMID: 18250265 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.

    Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW.

    Circulation. 2004 May 18;109(19):2273-8. Epub 2004 May 3.PMID: 15123524 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data